Skip to main content
Article thumbnail
Location of Repository

Attitudes toward Methadone among Out-of-Treatment Minority Injection Drug Users: Implications for Health Disparities

By Nickolas D. Zaller, Alexander R. Bazazi, Lavinia Velazquez and Josiah D. Rich

Abstract

Injection drug use (IDU) continues to be a significant public health issue in the U.S. and internationally, and there is evidence to suggest that the burden of injection drug use and associated morbidity and mortality falls disproportionately on minority communities. IDU is responsible for a significant portion of new and existing HIV/AIDS cases in many parts of the world. In the U.S., the prevalence of HIV and hepatitis C virus is higher among populations of African-American and Latino injection drug users (IDUs) than among white IDUs. Methadone maintenance therapy (MMT) has been demonstrated to effectively reduce opiate use, HIV risk behaviors and transmission, general mortality and criminal behavior, but opiate-dependent minorities are less likely to access MMT than whites. A better understanding of the obstacles minority IDUs face accessing treatment is needed to engage racial and ethnic disparities in IDU as well as drug-related morbidity and mortality. In this study, we explore knowledge, attitudes and beliefs about methadone among 53 out-of-treatment Latino and African-American IDUs in Providence, RI. Our findings suggest that negative perceptions of methadone persist among racial and ethnic minority IDUs in Providence, including beliefs that methadone is detrimental to health and that people should attempt to discontinue methadone treatment. Additional potential obstacles to entering methadone therapy include cost and the difficulty of regularly attending a methadone clinic as well as the belief that an individual on MMT is not abstinent from drugs. Substance use researchers and treatment professionals should engage minority communities, particularly Latino communities, in order to better understand the treatment needs of a diverse population, develop culturally appropriate MMT programs, and raise awareness of the benefits of MMT

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier: oai:pubmedcentral.nih.gov:2672350
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
    2. (1998). Accessing Drug-Abuse Treatment: Perceptions of Out-oftreatment Injectors.
    3. (1991). Ambivalence toward methadone treatment among intravenous drug users.
    4. (2008). Attitudes Toward Buprenorphine and Methadone Among Opioid-Dependent Individuals.
    5. (2002). Beliefs about methadone in an inner-city methadone clinic.
    6. (2003). Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care.
    7. (2004). Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification. Addiction
    8. (1993). Diminished illicit drug use as a consequence of long-term methadone maintenance. JAMA
    9. (2006). Disease Control and Prevention. HIV/AIDS Surveillance Report,
    10. (2002). Epidemiology of HIV/AIDS, Hepatitis B, Hepatitis C, and Tuberculosis Among Minority Injection Drug Users. Public Health Reports
    11. (2008). Estimating the Prevalence of Injection Drug Use among Black and White Adults in Large U.S. Metropolitan Areas over Time (1992-2002): Estimation Methods and Prevalence Trends.
    12. (2002). Estimating the Prevalence of Injection Drug Users
    13. (2001). Ethnic Disparities in Unmet Need for Alcoholism, Drug Abuse, and Mental Health Care.
    14. (2004). Heterogeneity among Latinas and Latinos entering substance abuse treatment: Findings from a national database.
    15. (2006). Hispanic drug abuse in an evolving cultural context: an agenda for research. Drug Alcohol Dependence
    16. (1993). Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
    17. (2006). Improving drug treatment services for Hispanics: research gaps and scientific opportunities. Drug Alcohol Depend.
    18. (1985). It takes your heart": the image of methadone maintenance in the addict world and its effect on recruitment into treatment.
    19. (2008). Methadone maintenance 4 decades later: thousands of lives saved but still controversial. JAMA
    20. (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
    21. (2000). Methadone Maintenance Treatment (MMT): A Review of Historical and Clinical
    22. (2000). Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA
    23. (2008). Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend.
    24. (2009). Need-service matching in substance abuse treatment: Racial/ethnic differences.
    25. (2008). Patterns of drug treatment entry by Latino male injection drug users from different national/geographical backgrounds.
    26. (2007). Probation and Parole in the United States,
    27. (2001). Racial and ethnic differences in drug treatment entry of injection drug users in
    28. (2005). Racial Identity Among Hispanics: Implications for Health and Well-Being.
    29. (1990). Racial/ethnic disparities in overdose mortality trends in
    30. (2004). Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand.
    31. (2007). Residential segregation and injection drug use prevalence among Black adults in US metropolitan areas.
    32. (2003). Substance Use, Dependence, and Service Utilization Among the US Uninsured Nonelderly Population.
    33. (2008). Substitution treatment of injecting opioid users for prevention of HIV infection.
    34. (1998). The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction
    35. (2001). The impact of harm-reductionbased methadone treatment on mortality among heroin users.
    36. (1999). The Street/Treatment Barrier: Treatment Experiences of Puerto Rican Injection Drug Users. Sub. Use Misuse
    37. (2008). Why don't out-of-treatment individuals enter methadone treatment programmes?

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.